drugset / Trial / NCT00708422
Effects of Travatan Z and Xalatan on Ocular Surface Health
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this randomized, double-masked, parallel-group, multicenter study is to evaluate ocular surface effects after the administration of travoprost with SofZia® preservative system or Xalatan once daily for 12 weeks.
Timeline
- Start
- 2008-07
- Primary completion
- 2009-08
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Latanoprost | Small molecule | 0.005 % | Topical |
| Subject | Travoprost | Other / unclassified | 0.004 % | Topical |